BVBiomed Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

BVBiomed General Information

Description

Developer of novel therapeutic compounds designed for use in treating neurodegenerative diseases. The company's research focuses on clinical trials to test the efficacy of the pregnancy-related peptide in treating acute exacerbation in multiple sclerosis, enabling users to utilize small molecules similar to relaxin for chronic treatment of the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Magdalen Centre, The Oxford Science Park
  • Robert Robinson Drive, Oxfordshire
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Magdalen Centre, The Oxford Science Park
  • Robert Robinson Drive, Oxfordshire
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BVBiomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jun-2023 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Clinical Trials - Phase 2
To view BVBiomed’s complete valuation and funding history, request access »

BVBiomed Patents

BVBiomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190000927-A1 Novel therapy Active 10-Sep-2015
WO-2017042577-A1 Novel therapy Inactive 10-Sep-2015
WO-2017042577-A8 Novel therapy Inactive 10-Sep-2015
US-11344607-B2 Treatment of disease with relaxin Active 10-Sep-2015
EP-2723366-A1 Relaxin proteins for use in the diagnosis, prevention or treatment of multiple sclerosis Active 24-Jun-2011 A61K38/2221
To view BVBiomed’s complete patent history, request access »

BVBiomed FAQs

  • When was BVBiomed founded?

    BVBiomed was founded in 2012.

  • Where is BVBiomed headquartered?

    BVBiomed is headquartered in Oxford, United Kingdom.

  • What industry is BVBiomed in?

    BVBiomed’s primary industry is Drug Discovery.

  • Is BVBiomed a private or public company?

    BVBiomed is a Private company.

  • What is BVBiomed’s current revenue?

    The current revenue for BVBiomed is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process